Search Results 1251-1260 of 15445 for alt

1. A Study to Evaluate Gleolan to Enhance Tumor Visualization in Patients with Newly-diagnosed or Recurrent Meningioma - Mayo Clinic

   normal ALT (SGPT) < 2.5 X institutional upper limit of normal Creatinine Below upper limit of normal OR Creatinine clearance >60 mL/min/1.73 m2 for ...

2. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Alanine aminotransferase (ALT) and Aspartate transaminase (AST) 3 x ULN (≤ 5 x ULN for patients with liver involvement);; Calculated creatinine clearance ...

3. A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level ≥ 3 timesthe upper limit of normal, confirmed by repeated testing during screening ...

4. ICoN-1 Phase 3 Study Of The Efficacy And Safety Of Treatment With MNKD-101, Clofazimine Inhalation Suspension - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >1.5 times upper limit of normal (ULN) or total bilirubin >1.5 times ULN during screening.

5. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

   AST(SGOT)/ALT(SGPT) ≤ 2.5 × institutional upper limit of normal (ULN). creatinine Within normal institutional limits OR creatinine clearance ≥ 60 mL/min ...

6. Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma - Mayo Clinic

   Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase ...

7. Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression - Mayo Clinic

   AST (SGOT) and ALT (SGPT) < 2.5 times ULN. Acceptable renal function: Serum creatinine < 2.5 times ULN. Acceptable hematologic status: Absolute neutrophil ...

8. Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma - Mayo Clinic

   AST and ALT ≤ 3 x ULN (or ≤ 5.0 x ULN if hepatic metastases are present); Serum Albumin ≥ 3 g/dL; Patients must have normal pituitary function as defined ...

9. A Study To Evaluate Avacopan In Participants With ANCA-associated Vasculitis - Mayo Clinic

   Aspartate aminotransferase (AST), alanine aminotransferase (ALT), or alkaline phosphatase (ALP) >2.0 times the upper limit of normal (ULN). Total bilirubin ...

10. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

    AST(SGOT)/ALT(SGPT) ≤ 2.5 x IULN, or ≤ 5.0 x IULN if due to liver involvement by tumor; Creatinine ≤ 1.5 x IULN or glomerular filtration rate of ≥ 60 mL ...